RUGGERI, Rosaria Maddalena
 Distribuzione geografica
Continente #
EU - Europa 19.006
NA - Nord America 12.098
AS - Asia 6.828
SA - Sud America 2.377
Continente sconosciuto - Info sul continente non disponibili 570
AF - Africa 233
OC - Oceania 18
Totale 41.130
Nazione #
US - Stati Uniti d'America 11.802
RU - Federazione Russa 7.129
IT - Italia 6.093
SG - Singapore 2.757
BR - Brasile 2.009
CN - Cina 1.930
IE - Irlanda 1.529
SE - Svezia 1.323
HK - Hong Kong 735
DE - Germania 610
FR - Francia 563
VN - Vietnam 434
NL - Olanda 361
UA - Ucraina 344
FI - Finlandia 333
GB - Regno Unito 292
IN - India 248
BD - Bangladesh 146
CA - Canada 137
AR - Argentina 132
PL - Polonia 101
TR - Turchia 78
MX - Messico 73
IQ - Iraq 71
ZA - Sudafrica 71
EC - Ecuador 61
CO - Colombia 55
AT - Austria 51
CZ - Repubblica Ceca 51
JP - Giappone 50
BE - Belgio 46
ID - Indonesia 46
PK - Pakistan 44
MA - Marocco 43
UZ - Uzbekistan 42
VE - Venezuela 34
ES - Italia 33
SA - Arabia Saudita 30
CH - Svizzera 27
CL - Cile 27
TN - Tunisia 25
CI - Costa d'Avorio 24
AE - Emirati Arabi Uniti 19
PE - Perù 19
IR - Iran 18
MY - Malesia 18
KE - Kenya 17
LT - Lituania 17
AZ - Azerbaigian 16
CR - Costa Rica 16
DZ - Algeria 16
JM - Giamaica 16
PH - Filippine 16
PY - Paraguay 16
EG - Egitto 15
KZ - Kazakistan 14
AL - Albania 13
DO - Repubblica Dominicana 13
AU - Australia 12
IL - Israele 12
JO - Giordania 12
NP - Nepal 11
UY - Uruguay 11
PT - Portogallo 10
RS - Serbia 10
BG - Bulgaria 9
BO - Bolivia 9
HN - Honduras 9
PS - Palestinian Territory 9
DK - Danimarca 8
EU - Europa 8
LB - Libano 8
RO - Romania 8
GR - Grecia 7
KG - Kirghizistan 7
BY - Bielorussia 6
GE - Georgia 6
GT - Guatemala 6
HU - Ungheria 6
LV - Lettonia 6
OM - Oman 6
SN - Senegal 6
SV - El Salvador 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
NO - Norvegia 5
PA - Panama 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
KR - Corea 4
LK - Sri Lanka 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
ET - Etiopia 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
NI - Nicaragua 3
SR - Suriname 3
Totale 40.526
Città #
Moscow 1.947
Ashburn 1.766
Dublin 1.522
Singapore 1.511
Dallas 1.245
Chandler 1.207
Hong Kong 731
Nyköping 700
Beijing 689
Jacksonville 687
San Jose 627
Milan 536
Rome 469
Council Bluffs 443
Messina 363
The Dalles 355
Los Angeles 270
Princeton 261
Lauterbourg 246
Dearborn 244
New York 231
Medford 226
Cambridge 203
Naples 203
Munich 187
Des Moines 184
Ann Arbor 162
São Paulo 151
Ho Chi Minh City 132
Turin 122
Buffalo 119
Boardman 106
Bologna 99
Catania 95
Bremen 93
Bari 91
Palermo 88
Santa Clara 86
Hanoi 79
Jinan 78
Tianjin 77
Warsaw 76
Redondo Beach 75
Turku 75
Florence 74
Wilmington 74
Guangzhou 71
Lancaster 65
Genoa 61
Pune 61
Helsinki 60
Dong Ket 58
Hyderabad 58
Nanjing 57
San Mateo 57
Frankfurt am Main 56
Woodbridge 54
Rio de Janeiro 52
Orem 50
Shenyang 50
Columbus 47
Brooklyn 45
Houston 45
Brasília 44
Brussels 44
Tokyo 43
Belo Horizonte 42
Denver 41
Johannesburg 41
Seattle 39
Montreal 38
Brescia 36
London 36
Vienna 36
Zhengzhou 36
San Francisco 35
Tashkent 35
Porto Alegre 33
Chennai 31
Chicago 31
Parma 31
Shenzhen 31
Shanghai 30
Atlanta 29
Hebei 29
Modena 29
Trieste 29
Ningbo 28
Verona 28
Cagliari 27
Haikou 27
Nuremberg 27
Brno 26
Hangzhou 25
Abidjan 24
Baghdad 24
Curitiba 24
Pisa 24
Salvador 24
Stockholm 24
Totale 21.133
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.701
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 739
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 328
IL GRADO DI COINVOLGIMENTO CUTANEO, VALUTATO COME SKIN SCORE SECONDO RODNAN, NEI PAZIENTI CON SCLEROSI SISTEMICA (SS) CORRELA CON I LIVELLI SIERICI DI TSH 325
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 280
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 258
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 249
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 217
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 211
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 210
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 209
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 208
Orticaria e Tireopatie autoimmuni. 205
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 202
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 200
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 199
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 198
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 198
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 197
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 194
Association of parathyroid carcinoma and thyroid disorders: A clinical review 194
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 193
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 190
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 190
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 188
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 187
Hyaluronan oligosaccharides induce inflammatory response in human thyrocytes cultures by affecting Toll-like receptors 186
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 185
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 185
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 184
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 184
AUMENTATO STRESS OSSIDATIVO NELLA TIROIDITE DI HASHIMOTO (TH) CON EUTIROIDISMO 184
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 183
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 182
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 182
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 182
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 182
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 180
HER2 analysis in sporadic thyroid cancer of follicular cell origin 179
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 177
I livelli sierici di Interleuchina 37 (IL-37) sono aumentati nella Tiroidite di Hashimoto (TH) e correlano con i marcatori di stress ossidativo 176
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 174
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 174
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 173
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 173
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 173
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 172
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 171
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 171
Oxidative stress as a key feature of autoimmune thyroiditis: an update 171
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 170
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 170
Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes 170
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 170
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 169
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 169
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 169
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 168
Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues 168
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 167
Malattie della Tiroide-Note di anatomia e fisiologia 166
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 166
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 165
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 164
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 164
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 163
Could AGE/RAGE-related oxidative homeostasis dysregulation enhance susceptibility to pathogenesis of cardio-metabolic complications in childhood obesity? 162
Predictive markers of recurrence in radically resected pituitary macroadenomas 160
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 160
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 159
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 159
Hyperthyroidism treatment with calculated activity of 131–radioiodine 159
An uncommon case of Marine-Lenhart syndrome 159
Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women 159
Iodine-131 treatment of hyperthyroidism: our experience 158
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 157
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 157
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 156
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 155
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 155
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 155
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 155
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 154
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 154
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 154
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 153
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 152
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 152
La paratiroidectomia radioguidata 151
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 151
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 151
Hyaluronan oligosaccharides down-regulate NIS and thyroglobulin expression in human thyrocytes 150
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 149
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 149
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 148
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 148
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 148
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 147
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 145
Bilateral cyclic cheek lesions related to premenstrual syndrome: a multifactorial pathogenesis? 145
Totale 22.857
Categoria #
all - tutte 125.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.836 0 215 43 105 77 29 101 95 38 299 247 587
2022/20234.804 362 431 232 340 384 534 78 273 1.863 45 178 84
2023/20242.547 111 189 168 216 179 425 121 182 102 271 199 384
2024/20258.349 298 240 372 619 586 404 381 1.521 1.569 587 685 1.087
2025/202617.987 999 1.265 1.273 1.104 1.481 3.585 2.111 2.161 2.356 881 380 391
2026/20271.136 405 731 0 0 0 0 0 0 0 0 0 0
Totale 41.130